Oncogenic Osteomalacia: An Approach to Diagnosis with a Case Report
Author:
Open Access
- 1 January 2017
- journal article
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 11 (4) , ED05-ED07
Abstract
Oncogenic osteomalacia, also known as tumour induced osteomalacia, is a rare paraneoplastic syndrome caused by mesenchymal tumours secreting Fibroblast Growth Factor-23 (FGF-23). The characteristic biochemical findings include hypophosphatemia and low 1,25-dihydroxy vitamin D. The differential diagnosis for hypophosphatemia are varied. We present a case of oncogenic osteomalacia in a 29-year-old female, who presented with complaints of generalized diffuse bone pain and walking difficulty for six months duration. Thus, we have discussed the approach to diagnosis in such a case.Keywords
This publication has 6 references indexed in Scilit:
- Oncogenic Osteomalacia Caused by Phosphaturie Mesenchymal Tumours in the Proximal and Shaft of the Tibia: A Case ReportJournal of Orthopaedic Surgery, 2014
- Tumor(s) Induced Osteomalacia—A Curious Case of Double TroubleThe Journal of Clinical Endocrinology & Metabolism, 2014
- Tumor-induced osteomalaciaEndocrine-Related Cancer, 2011
- Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1European Journal of Endocrinology, 2008
- Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic EntityAmerican Journal of Surgical Pathology, 2004
- Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or ricketsCancer, 1987